Skip to main content

Seaport Therapeutics, Inc.

SPTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0002042347

No open-market purchases or sales by Seaport Therapeutics, Inc. insiders were filed in the last 90 days; 54 institutions reported holding it in 13F filings for Q2 2026, worth $815.3M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Seaport Therapeutics, Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of SPTX: Q1 2026 compared with Q2 2026
MeasureQ1 2026Q2 2026Change
Holders054+54
Shares037.5M+37.5M
Value$0$815.3M+$815.3M

New holders (54)

Institutions that held Seaport Therapeutics, Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to SPTX in Q2 2026
InstitutionSharesValue% of portfolio
ARCH Venture Management, LLC6,294,951$136.6M12.42%
General Atlantic LLC6,101,582$132.5M4.56%
Sofinnova Investments, Inc.3,564,871$77.4M4.14%
Goldman Sachs Group Inc2,178,642$47.3M0.00%
TRV GP VI, LLC2,061,222$44.8M19.27%
Canada Pension Plan Investment Board1,975,791$42.9M0.02%
JPMorgan Chase & Co1,815,845$40.9M0.00%
Foresite Capital Management VI LLC1,779,521$38.7M6.02%
Price T Rowe Associates Inc1,308,604$28.4M0.00%
FMR LLC1,185,100$25.7M0.00%
Bellevue Group AG1,100,000$23.9M0.50%
Siren, L.L.C.1,095,316$23.8M0.48%
Jennison Associates LLC1,079,669$23.5M0.01%
Ra Capital Management, L.P.700,000$15.2M0.13%
Vanguard Capital Management LLC599,217$13.0M0.00%
Woodline Partners LP586,345$12.7M0.04%
Perceptive Advisors LLC500,000$10.9M0.17%
Braidwell LP500,000$10.9M0.40%
Principal Financial Group Inc414,672$9.01M0.00%
Standard Life Aberdeen plc310,355$6.74M0.01%
UBS Group AG279,184$6.06M0.00%
BlackRock, Inc.229,863$4.99M0.00%
Seven Grand Managers, LLC225,000$4.89M0.20%
Citadel Advisors LLC191,144$4.15M0.00%
Geode Capital Management, LLC175,866$3.82M0.00%
Pier Capital, LLC169,985$3.69M0.49%
Ameriprise Financial Inc131,788$2.86M0.00%
Charles Schwab Investment Management Inc97,693$2.12M0.00%
Vanguard Fiduciary Trust Co87,772$1.91M0.00%
Pentwater Capital Management LP83,000$1.80M0.01%
Manufacturers Life Insurance Company, The82,565$1.79M0.00%
Alyeska Investment Group, L.P.75,000$1.63M0.00%
State Street Corp66,650$1.45M0.00%
Alps Advisors Inc54,328$1.18M0.01%
TD Asset Management Inc47,944$1.04M0.00%
Millennium Management LLC45,337$984.7K0.00%
Gsa Capital Partners LLP33,178$721.0K0.05%
DAFNA Capital Management LLC32,400$703.7K0.13%
Northern Trust Corp31,802$690.7K0.00%
ADAR1 Capital Management, LLC26,000$564.7K0.03%
Ghisallo Capital Management LLC25,000$543.0K0.01%
Burkehill Global Management, LP25,000$543.0K0.02%
Squarepoint Ops LLC24,753$537.6K0.00%
HighTower Advisors, LLC16,666$362.0K0.00%
Morgan Stanley11,692$254.0K0.00%
XTX Topco Ltd10,983$238.6K0.00%
Weiss Asset Management LP10,000$217.2K0.00%
Zimmer Partners, LP10,000$217.2K0.01%
Vanguard Portfolio Management LLC9,081$197.2K0.00%
Vanguard Global Advisers, LLC7,159$155.5K0.00%
Citigroup Inc2,454$53.3K0.00%
Jones Financial Companies LLLP2,256$48.3K0.00%
Assetmark, Inc1,431$31.1K0.00%
Barclays PLC837$18.2K0.00%

Sold out (0)

Institutions that held Seaport Therapeutics, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

None.